Nialipin 400 mg

FDA Statement of Identity

Dietary Supplement

Formulation re: Other

Nialipin is well-tolerated by sensitive individuals.

Suggested/Recommended/Usage/Directions

Hypersensitive individuals are advised to start with one tablet prior to increasing dosage. Each sustained-release tablet is designed to release niacin over a period of 6 to 8 hours. Do not cut tablets in half.

Suggested/Recommended/Usage/Directions

Directions Take or or two tablets daily, or as directed by a physician.

Precautions re: Pregnant or Nursing or Prescription Medications

Do not take niacin unless recommended by and taken under the supervision of a physician if you have any of the following conditions: gallbladder disease, gout, arterial bleeding, glaucoma, diabetes, impaired liver function, peptic ulcer, or if you are pregnant or lactating.

General Statements: All Other Content

Ecological Formulas

Formula re: Contains

Sustained-release niacin

Formulation re: Does NOT Contain

Gluten free, casein free

FDA Disclaimer Statement

This product has not been evaluated by the FDA. This product is not intended to diagnose, cure, treat or prevent any disease.